COBRA APOTHEEK: what changed
What changed
COBRA APOTHEEK
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€193,902
2024 · €152,454+€41,448
Equity
€670,932
2024 · €577,030+€93,902
Cash
€168,433
2024 · €245,281-€76,848
Balance sheet total
€1.9m
2024 · €2.0m-€151,295
Largest movements
Assets
- Receivables within one year -€165,104
down €165,104 (-18.4%), from €899,210 to €734,106
of which Other amounts receivable: -€484,155
- Cash -€76,848
down €76,848 (-31.3%), from €245,281 to €168,433
mainly Other debts (-€334,817) and Investment in fixed assets (net) (-€113,380)
- Tangible fixed assets +€40,102
up €40,102 (+12.1%), from €330,347 to €370,449
of which Plant, machinery and equipment: +€38,039
- Stocks and contracts +€35,385
up €35,385 (+7.2%), from €488,266 to €523,651
Equity and liabilities
- Other debts -€334,817
down €334,817 (-64.6%), from €518,282 to €183,465
- Trade debts +€96,195
up €96,195 (+19.6%), from €491,275 to €587,470
- Reserves +€95,000
up €95,000 (+16.8%), from €564,031 to €659,031
- Debts after one year -€62,198
down €62,198 (-23.4%), from €266,214 to €204,016
- Accrued charges and deferred income +€48,250
up €48,250 (+264%), from €18,300 to €66,550
Income statement
- Gross operating margin +€24,271
up €24,271 (+2.4%), from €998,377 to €1.0m
- Staff costs -€16,369
down €16,369 (-2.2%), from €736,529 to €720,160
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€152,454
Gross operating margin
+€24,271
Staff costs
+€16,369
Depreciation
+€2,504
Other operating charges
-€231
Financial income
-€9,963
Financial charges
+€3,120
Taxes
+€5,377
Result 2025
€193,902
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€187,540
Investment
-€113,380
Financing
-€151,008
Cash 2024
€245,281
From operations (derived)
+€187,540
Net result for the year
+€193,902
Depreciation
+€73,278
Stocks and contracts
-€35,385
Receivables within one year
+€165,104
Deferred charges and accrued income
-€15,170
Trade debts
+€96,195
Tax, wage and social debts
-€3,816
Other debts
-€334,817
Accrued charges and deferred income
+€48,250
Investment (derived)
-€113,380
Investment in fixed assets (net)
-€113,380
Financing
-€151,008
Debts after one year
-€62,198
Current portion of long-term debt
+€1,046
Short-term financial debts
+€10,143
Contributions, distributions and other
-€100,000
Cash 2025
€168,433
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,023,289 | €1,871,994 | -€151,295 | -7.5% |
| Fixed assets | 21/28 | €330,347 | €370,449 | +€40,102 | +12.1% |
| Tangible fixed assets | 22/27 | €330,347 | €370,449 | +€40,102 | +12.1% |
| Land and buildings | 22 | €51,487 | €47,526 | -€3,961 | -7.7% |
| Plant, machinery and equipment | 23 | €276,880 | €314,919 | +€38,039 | +13.7% |
| Furniture and vehicles | 24 | €1,979 | €8,004 | +€6,025 | +304% |
| Other tangible fixed assets | 26 | €0 | - | = | |
| Current assets | 29/58 | €1,692,943 | €1,501,545 | -€191,397 | -11.3% |
| Stocks and contracts in progress | 3 | €488,266 | €523,651 | +€35,385 | +7.2% |
| Stocks | 30/36 | €488,266 | €523,651 | +€35,385 | +7.2% |
| Amounts receivable within one year | 40/41 | €899,210 | €734,106 | -€165,104 | -18.4% |
| Trade receivables | 40 | €364,832 | €683,884 | +€319,051 | +87.5% |
| Other amounts receivable | 41 | €534,378 | €50,223 | -€484,155 | -90.6% |
| Current investments | 50/53 | €5,000 | €5,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €245,281 | €168,433 | -€76,848 | -31.3% |
| Deferred charges and accrued income | 490/1 | €55,185 | €70,355 | +€15,170 | +27.5% |
| Total equity and liabilities | 10/49 | €2,023,289 | €1,871,994 | -€151,295 | -7.5% |
| Equity | 10/15 | €577,030 | €670,932 | +€93,902 | +16.3% |
| Contributions | 10/11 | €9,594 | €9,594 | = | 0.0% |
| Reserves | 13 | €564,031 | €659,031 | +€95,000 | +16.8% |
| Distributable reserves | 133 | €564,031 | €659,031 | +€95,000 | +16.8% |
| Profit (loss) carried forward | 14 | €3,405 | €2,307 | -€1,098 | -32.2% |
| Amounts payable | 17/49 | €1,446,260 | €1,201,062 | -€245,197 | -17.0% |
| Amounts payable after more than one year | 17 | €266,214 | €204,016 | -€62,198 | -23.4% |
| Financial debts | 170/4 | €266,214 | €204,016 | -€62,198 | -23.4% |
| Amounts payable within one year | 42/48 | €1,161,746 | €930,497 | -€231,249 | -19.9% |
| Current portion of amounts payable after more than one year | 42 | €61,152 | €62,198 | +€1,046 | +1.7% |
| Financial debts | 43 | €0 | €10,143 | +€10,143 | |
| Credit institutions | 430/8 | €0 | €10,143 | +€10,143 | |
| Trade debts | 44 | €491,275 | €587,470 | +€96,195 | +19.6% |
| Suppliers | 440/4 | €491,275 | €587,470 | +€96,195 | +19.6% |
| Taxes, remuneration and social security | 45 | €91,037 | €87,221 | -€3,816 | -4.2% |
| Taxes | 450/3 | €10,350 | €7,163 | -€3,188 | -30.8% |
| Remuneration and social security | 454/9 | €80,687 | €80,058 | -€628 | -0.8% |
| Other amounts payable | 47/48 | €518,282 | €183,465 | -€334,817 | -64.6% |
| Accrued charges and deferred income | 492/3 | €18,300 | €66,550 | +€48,250 | +264% |
| Remuneration, social security and pensions | 62 | €736,529 | €720,160 | -€16,369 | -2.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €75,782 | €73,278 | -€2,504 | -3.3% |
| Other operating charges | 640/8 | €1,844 | €2,075 | +€231 | +12.5% |
| Gross operating margin | 9900 | €998,377 | €1,022,648 | +€24,271 | +2.4% |
| Operating profit (loss) | 9901 | €184,222 | €227,135 | +€42,914 | +23.3% |
| Financial income | 75/76B | €18,433 | €8,471 | -€9,963 | -54.0% |
| Recurring financial income | 75 | €18,433 | €8,471 | -€9,963 | -54.0% |
| Financial charges | 65/66B | €11,319 | €8,199 | -€3,120 | -27.6% |
| Recurring financial charges | 65 | €11,319 | €8,199 | -€3,120 | -27.6% |
| Profit (loss) for the period before taxes | 9903 | €191,336 | €227,407 | +€36,071 | +18.9% |
| Income taxes | 67/77 | €38,882 | €33,505 | -€5,377 | -13.8% |
| Profit (loss) for the period | 9904 | €152,454 | €193,902 | +€41,448 | +27.2% |
| Profit (loss) for the period to be appropriated | 9905 | €152,454 | €193,902 | +€41,448 | +27.2% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.